Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Norwegian COgnitive Impairment After STroke (NorCOAST) Study

NCT02650531 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02650531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Norwegian COgnitive Impairment After STroke (NorCOAST) Study
Lead sponsor
Norwegian University of Science and Technology
Phase
Observational
Overall status
Completed
Start date
May 31, 2015
Completion date
October 8, 2018
Enrollment
816 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, mild cognitive impairment, stroke